{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:02:24Z","timestamp":1784721744725,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"DOI":"10.1007\/s00059-026-05390-w","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:16:55Z","timestamp":1784719015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective analysis of serum low-density lipoprotein cholesterol goal attainment and cardiovascular outcomes in coronary heart disease","Retrospektive Analyse der Zielerreichung beim Low-Density-Lipoprotein-Cholesterin im Serum und kardiovaskul\u00e4res Outcome bei koronarer Herzkrankheit"],"prefix":"10.1007","author":[{"given":"Ying","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"5390_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/JCN.0000000000001200","author":"G Victor","year":"2024","unstructured":"Victor\u00a0G, Shishani\u00a0K, Vellone\u00a0E, Froelicher\u00a0ES (2024) The Global Burden of Cardiovascular Disease in Adults: A Mapping Review. Journal of Cardiovascular Nursing. https:\/\/doi.org\/10.1097\/JCN.0000000000001200","journal-title":"Journal of Cardiovascular Nursing"},{"issue":"10258","key":"5390_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a\u00a0systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England) 396(10258):1204\u20131222","journal-title":"Lancet (London, England)"},{"key":"5390_CR3","unstructured":"World Health Organization (WHO) (2020) WHO Methods and Data Sources for Global Burden of Disease Estimates 2000\u20132019. Global Health Estimates Technical Paper WHO\/ DDI\/DNA\/GHE\/2020.3. https:\/\/cdn.who.int\/media\/docs\/default-source\/gho-documents\/global-health-estimates\/ghe2019_daly-methods.pdf. Accessed 25 Dec 2022"},{"issue":"25","key":"5390_CR4","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth\u00a0GA, Mensah\u00a0GA, Johnson\u00a0CO, Addolorato\u00a0G, Ammirati\u00a0E, Baddour\u00a0LM, Barengo\u00a0NC, Beaton\u00a0AZ, Benjamin\u00a0EJ, Benziger\u00a0CP, Bonny\u00a0A, Brauer\u00a0M, Brodmann\u00a0M, Cahill\u00a0TJ, Carapetis\u00a0J, Catapano\u00a0AL, Chugh\u00a0SS, Cooper\u00a0LT, Coresh\u00a0J, Criqui\u00a0M, GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group et\u00a0al (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. Journal of the American College of Cardiology 76(25):2982\u20133021","journal-title":"Journal of the American College of Cardiology"},{"issue":"15","key":"5390_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.46234\/ccdcw2021.087","volume":"3","author":"J Liu","year":"2021","unstructured":"Liu\u00a0J, Qi\u00a0J, Yin\u00a0P, Liu\u00a0Y, You\u00a0J, Lin\u00a0L, Zhou\u00a0M, Wang\u00a0L (2021) Cardiovascular Disease Mortality - China, 2019. China CDC weekly 3(15):323\u2013326","journal-title":"China CDC weekly"},{"issue":"11","key":"5390_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2023.102875","volume":"17","author":"A Rastogi","year":"2023","unstructured":"Rastogi\u00a0A, Sudhayakumar\u00a0A, Schaper\u00a0NC, Jude\u00a0EB (2023) A\u00a0paradigm shift for cardiovascular outcome evaluation in diabetes: major adverse cardiovascular events (MACE) to major adverse vascular events (MAVE). Diabetes & Metabolic Syndrome: Clinical Research & Reviews 17(11):102875","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews"},{"issue":"1","key":"5390_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02657-9","volume":"24","author":"BD Cordoba-Melo","year":"2025","unstructured":"Cordoba-Melo\u00a0BD, Seni-Molina\u00a0S, Arango-Ibanez\u00a0JP, Ayala\u00a0MR, Tatis-M\u00e9ndez\u00a0JF, Quintero Yepez\u00a0V, Mej\u00eda Cadavid\u00a0LA, Cruz-Cuevas\u00a0JD, Ariza-Ord\u00f3\u00f1ez\u00a0N, Buitrago\u00a0A, Lopez-Lopez\u00a0JP, Hinestrosa\u00a0A, Sabogal\u00a0J, Reyes-Vargas\u00a0C, Herrera-Escandon \u00c1, Hurtado\u00a0JS, Vel\u00e1squez Osorio\u00a0JF, Londo\u00f1o\u00a0S, Salamanca\u00a0C, Vallecilla\u00a0L, EDHIPO MARCA Research Group et\u00a0al (2025) From guidelines to practice: LDL\u2011C achievement in very high cardiovascular risk patients - analysis of the EDHIPO MARCA registry. Lipids in health and disease 24(1):275","journal-title":"Lipids in health and disease"},{"issue":"24","key":"5390_CR8","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n\u00a0J, Chapman\u00a0MJ, Krauss\u00a0RM, Packard\u00a0CJ, Bentzon\u00a0JF, Binder\u00a0CJ, Daemen\u00a0MJ, Demer\u00a0LL, Hegele\u00a0RA, Nicholls\u00a0SJ, Nordestgaard\u00a0BG, Watts\u00a0GF, Bruckert\u00a0E, Fazio\u00a0S, Ference\u00a0BA, Graham\u00a0I, Horton\u00a0JD, Landmesser\u00a0U, Laufs\u00a0U, Masana\u00a0L, Ginsberg\u00a0HN et\u00a0al (2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. European heart journal 41(24):2313\u20132330","journal-title":"European heart journal"},{"issue":"12","key":"5390_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1080\/14728222.2023.2288272","volume":"27","author":"CL Galindo","year":"2023","unstructured":"Galindo\u00a0CL, Khan\u00a0S, Zhang\u00a0X, Yeh\u00a0YS, Liu\u00a0Z, Razani\u00a0B (2023) Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets. Expert opinion on therapeutic targets 27(12):1231\u20131245","journal-title":"Expert opinion on therapeutic targets"},{"issue":"5","key":"5390_CR10","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1365-2125.2003.02060.x","volume":"57","author":"BM Cheung","year":"2004","unstructured":"Cheung\u00a0BM, Lauder\u00a0IJ, Lau\u00a0CP, Kumana\u00a0CR (2004) Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. British journal of clinical pharmacology 57(5):640\u2013651","journal-title":"British journal of clinical pharmacology"},{"key":"5390_CR11","doi-asserted-by":"crossref","unstructured":"Liu\u00a0Y, Lv\u00a0Z, Yan\u00a0H, Liu\u00a0Y, Zhang\u00a0J, Bian\u00a0W, et al (2025) Time in LDL Cholesterol Target Range and Major Adverse Cardiovascular Events Risk: A\u00a0Pooled Analysis of Two Cohorts. American Journal of Preventive Cardiology, 101290","DOI":"10.1016\/j.ajpc.2025.101290"},{"key":"5390_CR12","volume-title":"Lipidology update: targets and timing of well-established therapies","author":"L Guasti","year":"2024","unstructured":"Guasti\u00a0L, Lupi\u00a0A (2024) Lipidology update: targets and timing of well-established therapies. European Society of Cardiology, Sophia Antipolis Cedex"},{"issue":"13","key":"5390_CR13","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1093\/eurjpc\/zwaf235","volume":"32","author":"GS Greenberg","year":"2025","unstructured":"Greenberg\u00a0GS, Lorenzatti\u00a0D, Filtz\u00a0A, Jaspan\u00a0VN, Park\u00a0CM, Kalich\u00a0B, Kathe\u00a0N, Sidelnikov\u00a0E, Di Palo\u00a0KE, Browne\u00a0C, Lipsitz\u00a0E, Forest\u00a0S, Scotti\u00a0A, Latib\u00a0A, Garcia\u00a0MJ, Rodriguez\u00a0CJ, Shapiro\u00a0MD, Gulati\u00a0M, Slipczuk\u00a0L (2025) Disparities in achieving low-density lipoprotein cholesterol goals after revascularization in a\u00a0diverse real-world cohort. European journal of preventive cardiology 32(13):1192\u20131201","journal-title":"European journal of preventive cardiology"},{"key":"5390_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001423","author":"RS Blumenthal","year":"2026","unstructured":"Blumenthal\u00a0RS, Morris\u00a0PB, Gaudino\u00a0M, Johnson\u00a0HM, Anderson\u00a0TS, Bittner\u00a0VA et\u00a0al (2026) ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. https:\/\/doi.org\/10.1161\/CIR.0000000000001423","journal-title":"Circulation"},{"issue":"1","key":"5390_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12944-025-02657-9","volume":"24","author":"BD Cordoba-Melo","year":"2025","unstructured":"Cordoba-Melo\u00a0BD, Seni-Molina\u00a0S, Arango-Ibanez\u00a0JP, Ayala\u00a0MR, Tatis-M\u00e9ndez\u00a0JF, Quintero Yepez\u00a0V, Mej\u00eda Cadavid\u00a0LA, Cruz-Cuevas\u00a0JD, Ariza-Ord\u00f3\u00f1ez\u00a0N, Buitrago\u00a0A, Lopez-Lopez\u00a0JP, Hinestrosa\u00a0A, Sabogal\u00a0J, Reyes-Vargas\u00a0C, Herrera-Escandon \u00c1, Hurtado\u00a0JS, Vel\u00e1squez Osorio\u00a0JF, Londo\u00f1o\u00a0S, Salamanca\u00a0C, Vallecilla\u00a0L, EDHIPO MARCA Research Group et\u00a0al (2025) From guidelines to practice: LDL\u2011C achievement in very high cardiovascular risk patients - analysis of the EDHIPO MARCA registry. Lipids in health and disease 24(1):275\u2013275","journal-title":"Lipids in health and disease"},{"issue":"9","key":"5390_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093187","volume":"12","author":"V Barrios","year":"2023","unstructured":"Barrios\u00a0V, Pint\u00f3\u00a0X, Escobar\u00a0C, Varona\u00a0JF, G\u00e1mez\u00a0JM (2023) Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study. Journal of clinical medicine 12(9):3187","journal-title":"Journal of clinical medicine"},{"key":"5390_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijcard.2017.07.016","volume":"249","author":"Y Wang","year":"2017","unstructured":"Wang\u00a0Y, Yan\u00a0BP, Nichol\u00a0MB, Tomlinson\u00a0B, Lee\u00a0VWY (2017) Real-world study of low-density lipoprotein cholesterol levels and cardiovascular outcomes in Chinese: A retrospective cohort study in post-percutaneous coronary intervention acute coronary syndrome patients. International journal of cardiology 249:18\u201324","journal-title":"International journal of cardiology"},{"key":"5390_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcrp.2025.200468","volume":"26","author":"YC Chen","year":"2025","unstructured":"Chen\u00a0YC, Lu\u00a0JY, Huang\u00a0CY, Shao\u00a0ShaoYJ (2025) Associations of low-density lipoprotein cholesterol and hemoglobin A1C with cardiovascular events and mortality in breast and prostate cancer patients. International journal of cardiology. Cardiovascular risk and prevention 26:200468","journal-title":"International journal of cardiology. Cardiovascular risk and prevention"},{"key":"5390_CR19","doi-asserted-by":"crossref","unstructured":"Ngina\u00a0DM, Doehner\u00a0W, Ntaios\u00a0G, Nartey\u00a0Y, Akyea\u00a0RK (2025) Frequency of low-density-lipoprotein-cholesterol measurement and risk of major adverse cardiovascular outcomes: a\u00a05-million-person nationwide cohort study. Global Cardiology, 3(3)","DOI":"10.4081\/cardio.2025.85"},{"issue":"7","key":"5390_CR20","volume":"17","author":"SSUD Umer Khatab Gillani","year":"2025","unstructured":"Umer Khatab Gillani\u00a0SSUD, Ahmad Khan\u00a0A, Mobusher\u00a0M, Khalil\u00a0M, Ullah\u00a0S, Ullah\u00a0A, Hussain\u00a0BK, Iqbal\u00a0MM, Nayab\u00a0D, Ullah\u00a0N (2025) Assessment of Low-Density Lipoprotein Cholesterol (LDL-C) Target Attainment in High-Risk Patients Receiving Statin Plus Ezetimibe Therapy: A Retrospective Cross-Sectional Study. Cureus 17(7):e87963","journal-title":"Cureus"},{"issue":"2","key":"5390_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/medicina58020299","volume":"58","author":"J Vekic","year":"2022","unstructured":"Vekic\u00a0J, Zeljkovic\u00a0A, Cicero\u00a0AF, Janez\u00a0A, Stoian\u00a0AP, Sonmez\u00a0A, Rizzo\u00a0M (2022) Atherosclerosis development and progression: the role of atherogenic small, dense LDL. Medicina 58(2):299\u2013299","journal-title":"Medicina"},{"issue":"12","key":"5390_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/ehjacc\/zuac123","volume":"11","author":"KA Krychtiuk","year":"2022","unstructured":"Krychtiuk\u00a0KA, Ahrens\u00a0I, Drexel\u00a0H, Halvorsen\u00a0S, Hassager\u00a0C, Huber\u00a0K, Kurpas\u00a0D, Niessner\u00a0A, Schiele\u00a0F, Semb\u00a0AG, Sionis\u00a0A, Claeys\u00a0MJ, Barrabes\u00a0J, Montero\u00a0S, Sinnaeve\u00a0P, Pedretti\u00a0R, Catapano\u00a0A (2022) Acute LDL\u2011C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European heart journal. Acute cardiovascular care 11(12):939\u2013949","journal-title":"European heart journal. Acute cardiovascular care"},{"issue":"1","key":"5390_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-02618-5","volume":"22","author":"L Zhu","year":"2022","unstructured":"Zhu\u00a0L, Zheng\u00a0J, Gao\u00a0B, Jin\u00a0X, He\u00a0Y, Zhou\u00a0L, Huang\u00a0J (2022) The correlation between lipoprotein (a) elevations and the risk of recurrent cardiovascular events in CAD patients with different LDL\u2011C levels. BMC Cardiovascular Disorders 22(1):171","journal-title":"BMC Cardiovascular Disorders"},{"issue":"22","key":"5390_CR24","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.3390\/jcm11226838","volume":"11","author":"L Mueller","year":"2022","unstructured":"Mueller\u00a0L, Engelbertz\u00a0C, Reinecke\u00a0H, Freisinger\u00a0E, Malyar\u00a0NM, Meyborg\u00a0M, Brix\u00a0TJ, Varghese\u00a0J, Gebauer\u00a0K (2022) Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence. Journal of clinical medicine 11(22):6838","journal-title":"Journal of clinical medicine"},{"issue":"3","key":"5390_CR25","first-page":"371","volume":"73","author":"B \u015eim\u015fek","year":"2021","unstructured":"\u015eim\u015fek\u00a0B, \u0130nan\u00a0D, \u00c7\u0131nar\u00a0T, Cagdas-Yumurta\u015f\u00a0A, Ozan-Tan\u0131k\u00a0V, Zeren\u00a0G, \u0130lker-Avc\u0131 \u0130, Y\u00fccel-Karabay\u00a0C, G\u00fcng\u00f6r\u00a0B, Tokgozo\u011flu\u00a0L (2021) Evaluation of Low-density Lipoprotein Cholesterol Target Attainment Rates According to the 2016 and 2019 European Society of Cardiology\/European Atherosclerosis Society Dyslipidemia Guidelines for Secondary Prevention in Patients with Acute Myocardial Infarction. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 73(3):371\u2013378","journal-title":"Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion"},{"issue":"11","key":"5390_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028892","volume":"12","author":"MJ Wilkinson","year":"2023","unstructured":"Wilkinson\u00a0MJ, Lepor\u00a0NE, Michos\u00a0ED (2023) Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum. Journal of the American Heart Association 12(11):e028892","journal-title":"Journal of the American Heart Association"},{"issue":"1","key":"5390_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s40119-025-00397-6","volume":"14","author":"AR Kim","year":"2025","unstructured":"Kim\u00a0AR, Han\u00a0JY, Kim\u00a0M, Lee\u00a0H, Baek\u00a0YH, Ahn\u00a0I, Kang\u00a0HJ, Oh\u00a0JS, Kim\u00a0JH, Kwon\u00a0O, Jun\u00a0TJ, Kwon\u00a0SU, Kim\u00a0YH (2025) Cardiovascular Outcomes of Early LDL\u2011C Goal Achievement in Patients with Very-High-Risk ASCVD. Cardiology and therapy 14(1):101\u2013115","journal-title":"Cardiology and therapy"},{"issue":"7","key":"5390_CR28","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/j.clinthera.2021.04.019","volume":"43","author":"S Jin","year":"2021","unstructured":"Jin\u00a0S, Nie\u00a0X, Li\u00a0Y, Yuan\u00a0J, Cui\u00a0Y, Zhao\u00a0L (2021) Effect of More Intensive LDL-C\u2013Lowering Therapy on Long-term Cardiovascular Outcomes in Early-Phase Acute Coronary Syndrome: A Systematic Review and Meta-analysis. Clinical Therapeutics 43(7):e217\u2013e229","journal-title":"Clinical Therapeutics"},{"issue":"16","key":"5390_CR29","doi-asserted-by":"publisher","first-page":"E442","DOI":"10.1503\/cmaj.241713","volume":"197","author":"D Kang","year":"2025","unstructured":"Kang\u00a0D, Choi\u00a0KH, Yang\u00a0S, Kim\u00a0H, Park\u00a0TK, Lee\u00a0JM, Cho\u00a0J, Yang\u00a0JH, Song\u00a0YB, Choi\u00a0SH, Gwon\u00a0HC, Hahn\u00a0JY (2025) Clinical significance of low-density lipoprotein cholesterol percentage reduction and attained levels after percutaneous coronary intervention. CMAJ : Canadian Medical Association journal = journal de l\u2019Association medicale canadienne 197(16):E442\u2013E452","journal-title":"CMAJ : Canadian Medical Association journal = journal de l\u2019Association medicale canadienne"},{"key":"5390_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1653447","volume":"12","author":"KH Cho","year":"2025","unstructured":"Cho\u00a0KH, Yang\u00a0JH, Lee\u00a0SY, Shin\u00a0MH, Oh\u00a0S, Kim\u00a0MC, Sim\u00a0DS, Hong\u00a0YJ, Kim\u00a0JH, Ahn\u00a0Y, Lee\u00a0JH, Kwun\u00a0JS, Jeong\u00a0YH, Hahn\u00a0JY, Hwang\u00a0JY, Jeong\u00a0MH, Kim\u00a0W (2025) Long-term outcomes according to absolute value vs. percentage reduction in low-density lipoprotein cholesterol levels after acute myocardial infarction. Frontiers in cardiovascular medicine 12:1653447","journal-title":"Frontiers in cardiovascular medicine"},{"issue":"8","key":"5390_CR31","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1080\/00325481.2022.2117498","volume":"134","author":"J Underberg","year":"2022","unstructured":"Underberg\u00a0J, Toth\u00a0PP, Rodriguez\u00a0F (2022) LDL\u2011C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals. Postgraduate Medicine 134(8):752\u2013762","journal-title":"Postgraduate Medicine"},{"key":"5390_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1389106","volume":"11","author":"B Bashir","year":"2024","unstructured":"Bashir\u00a0B, Schofield\u00a0J, Downie\u00a0P, France\u00a0M, Ashcroft\u00a0DM, Wright\u00a0AK, Romeo\u00a0S, Gouni-Berthold\u00a0I, Maan\u00a0A, Durrington\u00a0PN, Soran\u00a0H (2024) Beyond LDL-C:\u00a0unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemia. Frontiers in cardiovascular medicine 11:1389106","journal-title":"Frontiers in cardiovascular medicine"},{"key":"5390_CR33","volume-title":"Endotext","author":"KR Feingold","year":"2025","unstructured":"Feingold\u00a0KR (2025) Guidelines for the Management of High Blood Cholesterol. In: Feingold\u00a0KR et\u00a0al (ed) Endotext. MDText.com, Inc,"},{"key":"5390_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100624","volume":"29","author":"KK Ray","year":"2023","unstructured":"Ray\u00a0KK, Haq\u00a0I, Bilitou\u00a0A, Manu\u00a0MC, Burden\u00a0A, Aguiar\u00a0C, Arca\u00a0M, Connolly\u00a0DL, Eriksson\u00a0M, Ferri\u00e8res\u00a0J, Laufs\u00a0U, Mostaza\u00a0JM, Nanchen\u00a0D, Rietzschel\u00a0E, Strandberg\u00a0T, Toplak\u00a0H, Visseren\u00a0FLJ, Catapano\u00a0AL, SANTORINI Study Investigators (2023) Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study. The Lancet regional health. Europe 29:100624","journal-title":"The Lancet regional health. Europe"},{"issue":"1","key":"5390_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.56095\/eaj.v1i1.10","volume":"1","author":"L Masana","year":"2022","unstructured":"Masana\u00a0L, Ibarretxe\u00a0D, Andreychuk\u00a0N, Royuela\u00a0M, Rodr\u00edguez-Borjabad\u00a0C, Plana\u00a0N (2022) Combination therapy in the guidelines: from high-intensity statins to high-intensity lipid-lowering therapies: combination therapy in the guideline. European Atherosclerosis Journal 1(1):25\u201329","journal-title":"European Atherosclerosis Journal"},{"issue":"1","key":"5390_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/clc.23935","volume":"46","author":"NR Desai","year":"2023","unstructured":"Desai\u00a0NR, Farbaniec\u00a0M, Karalis\u00a0DG (2023) Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease. Clinical cardiology 46(1):13\u201321","journal-title":"Clinical cardiology"},{"issue":"9","key":"5390_CR37","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s00392-022-02147-3","volume":"112","author":"U Makhmudova","year":"2023","unstructured":"Makhmudova\u00a0U, Samadifar\u00a0B, Maloku\u00a0A, Haxhikadrija\u00a0P, Geiling\u00a0JA, R\u00f6mer\u00a0R, Lauer\u00a0B, M\u00f6bius-Winkler\u00a0S, Otto\u00a0S, Schulze\u00a0PC, Weing\u00e4rtner\u00a0O (2023) Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (\u201cJena auf Ziel\u201d). Clin Res Cardiol 112(9):1212\u20131219. https:\/\/doi.org\/10.1007\/s00392-022-02147-3","journal-title":"Clinical research in cardiology : official journal of the German Cardiac Society"},{"key":"5390_CR38","volume":"377","author":"SU Khan","year":"2022","unstructured":"Khan\u00a0SU, Yedlapati\u00a0SH, Lone\u00a0AN, Hao\u00a0Q, Guyatt\u00a0G, Delvaux\u00a0N, Bekkering\u00a0GET, Vandvik\u00a0PO, Riaz\u00a0IB, Li\u00a0S, Aertgeerts\u00a0B, Rodondi\u00a0N (2022) PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a\u00a0systematic review and network meta-analysis. BMJ (Clinical research ed.) 377:e069116","journal-title":"BMJ (Clinical research ed.)"},{"issue":"2","key":"5390_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.14740\/cr1224","volume":"12","author":"J Lee","year":"2021","unstructured":"Lee\u00a0J, Egolum\u00a0U, Parihar\u00a0H, Cooley\u00a0M, Ling\u00a0H (2021) Effect of ezetimibe added to high-intensity statin therapy on low-density lipoprotein cholesterol levels: a\u00a0meta-analysis. Cardiology research 12(2):98\u201398","journal-title":"Cardiology research"},{"issue":"2","key":"5390_CR40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00392-025-02736-y","volume":"115","author":"F Haertel","year":"2026","unstructured":"Haertel\u00a0F, Makhmudova\u00a0U, Geiling\u00a0JA, Lauer\u00a0B, M\u00f6bius-Winkler\u00a0S, Otto\u00a0S, Schulze\u00a0PC, Weing\u00e4rtner\u00a0O (2026) Less intensive lipid-lowering therapy after ST-elevation myocardial infarction is associated with cardiovascular events: 2\u2011year follow-up of \u201cJena auf Ziel\u201d. Clin Res Cardiol 115(2):304\u2013312. https:\/\/doi.org\/10.1007\/s00392-025-02736-y","journal-title":"Clinical research in cardiology : official journal of the German Cardiac Society"},{"issue":"7","key":"5390_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076669","volume":"24","author":"LA Stanciulescu","year":"2023","unstructured":"Stanciulescu\u00a0LA, Scafa-Udriste\u00a0A, Dorobantu\u00a0M (2023) Exploring the association between low-density lipoprotein subfractions and major adverse cardiovascular outcomes\u2014a comprehensive review. International Journal of Molecular Sciences 24(7):6669","journal-title":"International Journal of Molecular Sciences"},{"key":"5390_CR42","doi-asserted-by":"crossref","unstructured":"Mhaimeed\u00a0O, Burney\u00a0ZA, Schott\u00a0SL, Kohli\u00a0P, Marvel\u00a0FA, Martin\u00a0SS (2024) The importance of LDL\u2011C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better. American Journal of Preventive Cardiology, 18, 100649","DOI":"10.1016\/j.ajpc.2024.100649"},{"issue":"12","key":"5390_CR43","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2512459","volume":"25","author":"X Zhang","year":"2024","unstructured":"Zhang\u00a0X, Feng\u00a0H, Han\u00a0Y, Yuan\u00a0X, Jiang\u00a0M, Wang\u00a0W, Gao\u00a0L (2024) Plaque Stabilization and Regression, from Mechanisms to Surveillance and Clinical Strategies. Reviews in cardiovascular medicine 25(12):459","journal-title":"Reviews in cardiovascular medicine"},{"issue":"5","key":"5390_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10050970","volume":"10","author":"AL Burger","year":"2022","unstructured":"Burger\u00a0AL, Pogran\u00a0E, Muthspiel\u00a0M, Kaufmann\u00a0CC, J\u00e4ger\u00a0B, Huber\u00a0K (2022) New treatment targets and innovative lipid-lowering therapies in very-high-risk patients with cardiovascular disease. Biomedicines 10(5):970","journal-title":"Biomedicines"},{"key":"5390_CR45","doi-asserted-by":"crossref","unstructured":"Lee\u00a0YJ, Lee\u00a0SJ, Kim\u00a0JW, Lee\u00a0SH, Kim\u00a0GS, Park\u00a0JH, Cho\u00a0JM, Kang\u00a0WC, Yoon\u00a0HJ, Kim\u00a0WH, Lee\u00a0SJ, Lee\u00a0JB, Jang\u00a0JY, Shin\u00a0S, Park\u00a0IH, Kwon\u00a0SU, Kim\u00a0S, Hong\u00a0SJ, Ahn\u00a0CM, Kim\u00a0JS, et al (2026) Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease. The New England journal of medicine, 394(14), 1365\u20131375","DOI":"10.1056\/NEJMoa2600283"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-026-05390-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-026-05390-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-026-05390-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:17:09Z","timestamp":1784719029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-026-05390-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":45,"alternative-id":["5390"],"URL":"https:\/\/doi.org\/10.1007\/s00059-026-05390-w","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study is approved by the Ethics Committee of Chinese PLA General Hospital. In accordance with the ethics committee\u2019s regulations, written informed consent was waived, given that the study did not intervene in patient care and posed no additional risk to participants.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was waived, given that the study did not intervene in patient care and posed no additional risk to participants.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this paper.","order":4,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}